Abstract:Male Sprague-Dawley rats (n = 18) were randomly divided into three groups: a saline group (20 mL/kg by gavage), a ketamine (KET) group (100 mg/kg by gavage), and a KET (the same routes and doses) combined with levo-tetrahydropalmatine (l-THP; 40 mg/kg by gavage) group (n = 6). Blood samples were acquired at different time points after drug administration. A simple and sensitive ultraperformance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method was established to determine the concentrations of KET and its metabolite, norketamine (NK), in rat plasma. Chromatographic separation was achieved using a BEH C18 column (2.1 mm × 50 mm, 1.7 μm) with chlorpheniramine maleate (Chlor-Trimeton) as an internal standard (IS). The initial mobile phase consisted of acetonitrile-water with 0.1% methanoic acid (80 : 20, v/v). The multiple reaction monitoring (MRM) modes of m/z 238.1→m/z 179.1 for KET, m/z 224.1→m/z 207.1 for NK, and m/z 275→m/z 230 for Chlor-Trimeton (IS) were utilized to conduct a quantitative analysis. Calibration curves of KET and NK in rat plasma demonstrated good linearity in the range of 2.5-500 ng/mL (r > 0.9994), and the lower limit of quantification (LLOQ) was 2.5 ng/mL for both. Moreover, the intra- and interday precision relative standard deviation (RSD) of KET and NK were less than 4.31% and 6.53%, respectively. The accuracies (relative error) of KET and NK were below -1.41% and -6.07%, respectively. The extraction recoveries of KET and NK were more than 81.23 ± 3.45% and 80.42 ± 4.57%, respectively. This sensitive, rapid, and selective UPLC-MS/MS method was successfully applied to study the pharmacokinetic effects of l-THP on KET after gastric gavage. The results demonstrated that l-THP could increase the bioavailability of KET and promote the metabolism of KET. The results showed that l-THP has pharmacokinetics effects on KET in rat plasma.

Studies on the pharmacokinetic-pharmacodynamic model of ketoprofen beta-CD inclusion complex in rabbits]

EVALUATIONS ON THE PHARMACODYNAMICS OF KETOPROFEN β-CYCLODEXTRIN INCLUSION COMPLEX PREPARATION IN ANIMALS

Determination of quercetin and kaempferal in rabbit plasma by HPLC

Antipyretic, Analgesic and Anti-Inflammatory Activities of Ketoprofen Beta-Cyclodextrin Inclusion Complexes in Animals.

Antipyretic, Analgesic and Anti-inflammatory Activities of Ketoprofen β-Cyclodextrin Inclusion Complexes in Animals

Studies on Simultaneous Determination and Pharmacokinetics of Two Bufadienolides in Rabbits Plasma

Pharmacokinetics of piroxicam-β-cyclodextrin inclusion complexes in Beagle dogs

Comparison of Pharmacokinetics of 10-Hydroxycamptothecin Between Nebulized Inhalation and Intravenous Administration in Rabbits

Pharmacokinetic study with N-Ile1-Thr2-63-desulfato-r-hirudin in rabbits by means of bioassay

Pharmacokinetics of osthol in the rabbits

Study on Pharmacokinetics and Bioavailability of Potassium Dehydroandrographolide Succinate Hollow Suppositories in Rabbits

Preparation of ketoprofen cataplasm and research on its skin penetration in vitro

Population total and unbound pharmacokinetics and pharmacodynamics of ciprofol and M4 in subjects with various renal functions

Pharmacokinetics and Intestinal Metabolism of Compound K in Rats and Mice

Pharmacokinetic Effects of l-Tetrahydropalmatine on Ketamine in Rat Plasma by Ultraperformance Liquid Chromatography Tandem Mass Spectrometry

Effect of ketamine on pharmacokinetics of efavirenz in rabbits

Determination of amphotericin B in rabbits plasma and pharmacokinetics investigation by HPLC

Propionic Acid Groups and Multiple Aromatic Rings Induce Binding of Ketoprofen and Naproxen to the Hydrophobic Core of Bovine Serum Albumin

Ketoprofen in horses: Metabolism, pharmacokinetics, and effects on inflammatory biomarkers

Absorption mechanism of kirenol and pharmacokinetic analysis of its sustained-release pellets in beagles

Phannacokinetics of Active Component of Chrysanthemum Morifolium Extracts and Its Acid Hydrolysate in Rabbits